ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,363Medicare Part D Prescriptions Filled, Including Refills

Rank: 61 out of 761

$595K Total Retail Price of All Prescriptions

Rank: 75 out of 761

494 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 494 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

14% of this provider’s 494 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 9,175 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
HYDROCODONE-ACETAMINOPHEN 497 286 S3 1 5
OMEPRAZOLE 494 386 2 4
LEVOTHYROXINE SODIUM 454 380 3 3
FUROSEMIDE 390 347 4 7
LISINOPRIL 332 307 5 1
SIMVASTATIN 310 293 6 2
POTASSIUM CHLORIDE 309 282 7 18
METFORMIN HCL 264 205 8 10
HYDROCHLOROTHIAZIDE 263 224 9 11
LOSARTAN POTASSIUM 231 214 10 13
TRAMADOL HCL 228 216 11 34
WARFARIN SODIUM 226 210 12 9
METOPROLOL TARTRATE 216 213 13 14
GABAPENTIN 212 174 14 15
ZOLPIDEM TARTRATE 180 113 15 22
METOPROLOL SUCCINATE 170 170 16 16
SPIRONOLACTONE 139 112 17 45
AMLODIPINE BESYLATE 137 126 18 6
ATORVASTATIN CALCIUM 121 121 19 12
MELOXICAM 120 104 20 61
FENTANYL 120 93 S2 20 57
ALLOPURINOL 116 107 22 28
TRAZODONE HCL 114 85 23 23
DILTIAZEM HCL 102 99 24 242
ALENDRONATE SODIUM 96 96 25 21
AMITRIPTYLINE HCL 96 62 R 25 54
DIGOXIN 90 87 27 43
CELEBREX 90 89 27 125
LANTUS 87 50 29 41
CLONIDINE HCL 87 86 29 69
PROPRANOLOL HCL 84 66 31 100
CLOPIDOGREL 84 81 31 66
CYMBALTA 77 46 33 53
PANTOPRAZOLE SODIUM 75 58 34 40
ATENOLOL 75 68 34 8
CITALOPRAM HBR 72 58 36 19
CARISOPRODOL 71 0 R 37 131
PREDNISONE 70 62 38 30
TAMSULOSIN HCL 61 61 39 27
METOCLOPRAMIDE HCL 59 56 40 149
CRESTOR 59 22 40 36
NAPROXEN 58 53 42 105
NEXIUM 57 50 43 98
GLIMEPIRIDE 57 44 43 48
OXYCODONE HCL 55 11 S2 45 24
ESTRADIOL 53 51 R 46 80
RISPERIDONE 52 40 47 83
DOXYCYCLINE HYCLATE 51 37 48 160
PLAVIX 51 50 48 119
PROAIR HFA 50 22 50 32
DILTIAZEM 24HR CD 50 49 50 132
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 24, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.